Cirqle Biomedical

Cirqle Biomedical is a pre-clinical women’s health company aiming to expand freedom and quality of life for women everywhere. Cirqle Biomedical is developing a first-in-class non-hormonal contraceptive that is being evaluated for its potential to make cervical mucus temporarily impenetrable to sperm and thereby prevent pregnancies. Cirqle Biomedical was launched in 2019 in Copenhagen, Denmark, with backing from BioInnovation Institute (BII) and RH Capital, a San Francisco-based impact investor dedicated to women’s reproductive health.

Contact name:

Frederik Petursson Madsen

Address:

Ole Maaløes Vej 3, 2200 Copenhagen N

Telephone:

+45 26831750

Established:

2019

Number of employees:

9

If you cannot find what you are looking for or if you have feedback to our website, please do not hesitate to contact dd@danskbiotek.dk or +45 5150 0560

Copyright 2021 DANISH BIO – DANSK BIOTEK. All rights reserved.